Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis
Author:
Affiliation:
1. State Key Laboratory of Natural Medicines
2. Department of Pharmaceutics
3. China Pharmaceutical University
4. Nanjing 210009
5. China
6. College of Animal Science and Technology
7. Zhejiang A&F University
8. Lin'an
Abstract
Herein, celecoxib (CLX) and brefeldin A (BFA) were encapsulated into the biocompatible polymer PLGA-PEG to form nanoparticles that act on the Golgi apparatus to treat metastatic breast cancer.
Funder
National Natural Science Foundation of China
Outstanding Youth Foundation of Jiangsu Province of China
Ministry of Education of the People's Republic of China
State Administration of Foreign Experts Affairs
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering
Link
http://pubs.rsc.org/en/content/articlepdf/2018/BM/C8BM00381E
Reference42 articles.
1. Cancer statistics, 2017
2. Metastasis: a question of life or death
3. Hypoxic control of metastasis
4. Tumor Metastasis: Molecular Insights and Evolving Paradigms
5. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances, limitations and perspectives in the use of celecoxib-loaded nanocarriers in therapeutics of cancer;Discover Nano;2024-09-06
2. Golgi apparatus targeted therapy in cancer: Are we there yet?;Life Sciences;2024-09
3. Self-Assembled Chemo/Photothermal Nanoplatform for Enhanced Cancer Therapy: Sensitizing Photothermal Ablation and Reprogramming Inflammatory Microenvironment;ACS Materials Letters;2024-07-26
4. A structure-guided strategy to design Golgi apparatus-targeted type-I/II aggregation-induced emission photosensitizers for efficient photodynamic therapy;Acta Biomaterialia;2024-07
5. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release;Advanced Drug Delivery Reviews;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3